VI
₹6.47
+0.30(+4.86%)
VISTAPH₹6.47+4.86%
38/100
0100 · strongest
moderatepartial
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %VISTAPH financial summary
For Mar 2026, Vista Pharmaceuticals Ltd reported revenue of ₹5 crore, which fell 50.0% from the previous year. Net profit was -₹12 crore, on an operating margin of -271%. Earnings per share came in at -₹1.96. Over the 5 years from Mar 2021 to Mar 2026, revenue changed at a compound annual rate of 38.0%. The highest operating margin in that period was -33% in Mar 2024. Annual results are available for 12 financial years, from Mar 2015 to Mar 2026.
| Revenue | ₹5 crore |
|---|---|
| Net profit | -₹12 crore |
| Operating margin | -271% |
| EPS | -₹1.96 |